Search

everythinglearnresearchcommunity

for

Search:↓

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Detailed history and physical examination are crucial for diagnosing hair loss.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

New treatments focusing on immune pathways show promise for stubborn hair loss.

A woman's hair loss led to discovering she had lupus.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.